• Home
  • Corporate Members
  • Exhibit Hall
  • About
  • Previous Conferences
    • WSMOS COVID-19 – June 25, 2020
    • WSMOS TeleHealth – July 2, 2020
    • WSMOS COVID-19 – UPDATES – October 29, 2020
  • Agenda
  • Contact
  • Regiser
  • Home
  • About us
  • Our services
  • Our clients
  • Contact

Please don’t hesitate to contact us.

Send a Request
© 2021 WSMOS Conference. All Rights Reserved. Disclaimers

      Company Overview

      Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology.

      With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. For more information, please visit: www.daiichisankyo.com.

      For more information, please visit: www.daiichisankyo.com. Daiichi Sankyo, Inc., headquartered in Basking Ridge, New Jersey, is a member of the Daiichi Sankyo Group. To learn more about Daiichi Sankyo, Inc., please visit www.dsi.com.

      daiichisankyo

      I Would Like Someone to Get in Touch With Me